A study to learn how vamorolone affects the body, how safe it is and how it moves into, through and out of the body in healthy male participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512101-60-00

Acronym

SNT-I-VAM-026

Enrollment

Registered

2024-05-06

Start date

2024-06-05

Completion date

2024-07-06

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phase I study in healthy male volunteers. Intended indication: Duchenne muscular dystrophy and Becker muscular dystrophy

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026